1. Pan, Mingang, Luo, Muyu, Liu, Lele, Huang, Ailong, Xia, Jie. 2024. EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL. In Journal of experimental & clinical cancer research : CR, 43, 35. doi:10.1186/s13046-024-02957-5. https://pubmed.ncbi.nlm.nih.gov/38287371/
2. Ma, Wenqi, Jia, Kangni, Cheng, Haomai, Zhang, Ruiyan, Yan, Xiaoxiang. 2024. Orphan Nuclear Receptor NR4A3 Promotes Vascular Calcification via Histone Lactylation. In Circulation research, 134, 1427-1447. doi:10.1161/CIRCRESAHA.123.323699. https://pubmed.ncbi.nlm.nih.gov/38629274/
3. Wang, Meiyue, Flaswinkel, Heinrich, Joshi, Abhinav, Fröhlich, Thomas, Hornung, Veit. 2024. Phosphorylation of PFKL regulates metabolic reprogramming in macrophages following pattern recognition receptor activation. In Nature communications, 15, 6438. doi:10.1038/s41467-024-50104-7. https://pubmed.ncbi.nlm.nih.gov/39085210/
4. Chen, Shengmiao, Wu, Yiran, Gao, Yang, Zhao, Suwen, Fan, Gaofeng. 2023. Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness. In Cell reports, 42, 113246. doi:10.1016/j.celrep.2023.113246. https://pubmed.ncbi.nlm.nih.gov/37831605/
5. Elson, A, Levanon, D, Weiss, Y, Groner, Y. . Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21. In The Biochemical journal, 299 ( Pt 2), 409-15. doi:. https://pubmed.ncbi.nlm.nih.gov/8172601/
智鼠故事 
